Clinical Trials on Stage IIB Non-Small Cell Lung Cancer in Korea, Democratic People's Republic of
Total 723 results
-
Millennium Pharmaceuticals, Inc.TerminatedSmall Cell Lung Cancer | Ovarian Cancer | Advanced Solid TumorsJapan, Korea, Republic of
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
AmgenCompletedSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Yuhan CorporationThe Korean Academy of Tuberculosis and Respiratory DiseasesActive, not recruiting
-
Clinical Research Center for Solid Tumor, KoreaCompletedSmall Cell Lung CancerKorea, Republic of
-
AstraZenecaCompletedNon Small Cell Lung CancerRussian Federation
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, France, United Kingdom, Hong Kong
-
NewLink Genetics CorporationCompletedNon-Small Cell Lung CancerRussian Federation, Ukraine
-
Ulsan University HospitalJeil Pharmaceutical Co., Ltd.UnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
PfizerOxOnc Development LPCompletedNon Small Cell Lung Cancer | Crizotinib | ROS1 Proto OncogeneKorea, Republic of, China, Taiwan, Japan
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Samsung Medical CenterRecruitingBreast Cancer Stage IIIKorea, Republic of
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands, Italy
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
BayerRecruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Korea, Republic of, Israel, Japan, China, Australia, Spain
-
Chonnam National University HospitalAstraZenecaCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Asan Medical CenterCompletedPleural Effusion, Malignant | Non-small Cell CarcinomaKorea, Republic of
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, United States, Spain, Germany
-
TakedaRecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseKorea, Republic of
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Germany, Spain, Netherlands, United Kingdom
-
AbbVieActive, not recruitingNon Small Cell Lung CancerUnited States, Australia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Taiwan
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
MedicalLogicKosin University Gospel HospitalUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Korean South West Oncology GroupUnknownCarcinoma, Non-Small-Cell Lung | Carcinoma, Large Cell | Carcinoma, SquamousKorea, Republic of
-
Regeneron PharmaceuticalsBioNTech SERecruitingAdvanced Non-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, Georgia, Taiwan, Germany, Turkey
-
AstraZenecaActive, not recruitingSmall-Cell Lung CancerPoland, Korea, Republic of, United States, Spain
-
Astex Pharmaceuticals, Inc.CompletedNon-small Cell Lung Cancer(NSCLC)United States, Korea, Republic of, Spain, France, Canada
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
Klus Pharma Inc.Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina, Spain, Turkey, Georgia, Korea, Republic of, Australia, Romania
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
Turning Point Therapeutics, Inc.TerminatedNon Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Medullary Thyroid Cancer | RET Gene MutationUnited States, Korea, Republic of
-
AnHeart Therapeutics Inc.RecruitingNon Small Cell Lung CancerUnited States, Spain, France, Italy, Japan, Korea, Republic of, Canada, China, Poland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Belgium, France, Italy, Spain, Brazil, Australia, Germany, Turkey, Mexico, United States
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Israel, Malaysia, Australia, Georgia, Turkey, Canada
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more